|
AU2003213963A8
|
|
Method of treating or preventing autoimmune disease
|
|
US2004110286A1
|
|
Method for making hematopoietic cells
|
|
EP1385429A2
|
|
Method and apparatus for calculating blood flow parameters
|
|
AU3715701A
|
|
Mistletoe extracts
|
|
EP1214089A1
|
|
Therapeutic uses of m3 polypeptide
|
|
CA2301675A1
|
|
Prostate boundary segmentation from 2d and 3d ultrasound images
|
|
AU1642000A
|
|
Chemokine binding protein and methods of use therefor
|
|
CA2298131A1
|
|
Automated segmentation method for 3-dimensional ultrasound
|
|
AU7348798A
|
|
Method for dislodging infiltrated leukocytes from a tissue
|
|
WO9846996A2
|
|
Lck serine phosphorylation assay for t-cell activation and activation-induced cell death
|
|
CA2276733A1
|
|
Methods and compositions for preventing autoimmune disease
|
|
AU5546298A
|
|
Methods and compositions for preventing autoimmune disease
|
|
WO9802153A1
|
|
Ceramide promotors of haematopoiesis
|
|
AU3332097A
|
|
Hybrid herpes virus/epstein-barr virus vector
|
